| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99233 |
Prolong inpt eval add15 m |
394,644 |
149,830 |
$23.95M |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
64,339 |
62,447 |
$11.52M |
| 99223 |
Prolong inpt eval add15 m |
45,514 |
43,302 |
$4.85M |
| 90961 |
|
32,217 |
31,162 |
$4.39M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
61,552 |
57,764 |
$2.77M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
41,979 |
20,779 |
$1.62M |
| 99215 |
Prolong outpt/office vis |
26,069 |
23,814 |
$1.48M |
| 36902 |
|
6,406 |
6,088 |
$897K |
| 93990 |
|
11,197 |
10,630 |
$889K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
4,567 |
1,734 |
$684K |
| 90962 |
|
5,874 |
5,682 |
$535K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
5,425 |
2,336 |
$290K |
| 93985 |
|
972 |
962 |
$182K |
| 90966 |
|
767 |
732 |
$94K |
| G0365 |
Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) |
576 |
464 |
$67K |
| 36821 |
|
132 |
127 |
$62K |
| 99205 |
Prolong outpt/office vis |
502 |
471 |
$51K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,678 |
1,406 |
$41K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
466 |
442 |
$40K |
| 90945 |
|
482 |
134 |
$30K |
| 99443 |
|
577 |
563 |
$28K |
| 99310 |
Prolong nursin fac eval 15m |
315 |
75 |
$22K |
| 99222 |
Initial hospital care, per day, moderate complexity |
347 |
316 |
$22K |
| 99442 |
|
481 |
471 |
$19K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
434 |
305 |
$16K |
| 90970 |
|
251 |
137 |
$14K |
| 36830 |
|
26 |
26 |
$12K |
| 76775 |
|
419 |
360 |
$9K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
52 |
41 |
$7K |
| 82570 |
|
1,117 |
1,073 |
$4K |
| 36901 |
|
37 |
36 |
$3K |
| 99441 |
|
154 |
151 |
$3K |
| 97802 |
|
45 |
39 |
$2K |
| 99305 |
|
27 |
27 |
$2K |
| 81003 |
|
1,615 |
1,539 |
$1K |
| 97803 |
|
43 |
37 |
$1K |
| 36589 |
|
12 |
12 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
55 |
39 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
58 |
39 |
$1K |
| 99220 |
|
14 |
13 |
$849.24 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
14 |
12 |
$603.19 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
280 |
216 |
$369.48 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,158 |
728 |
$318.20 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
35 |
27 |
$169.89 |
| 51798 |
|
22 |
17 |
$119.14 |
| J7050 |
Infusion, normal saline solution, 250 cc |
14 |
12 |
$2.82 |